This issue is isolated to one client, and cerner notified this client of the issue on december 19, 2017.The same day, cerner corrected the configuration and the issue was resolved.Cerner corporation considers this issue to be resolved and no further narrative is required for follow-up.
|
The issue involves cerner millennium medical device interfaces (mdi) which provides electronic communication between the lab testing instrument and cerner millennium pathnet system.Due to an incorrect configuration in mdi, when an order was placed for digoxin dta in pathnet, the lab testing instrument ran the dta for creatinine.The test result values for the creatinine dta were saved in pathnet as digoxin levels.Patient care could be adversely affected as clinicians may adjust the dosage of digoxin based on incorrect information which could lead to the patient receiving an overdose or underdose of the medication.Cerner has not received communication on any adverse patient events as a result of this issue.
|